ArticleClinical kidney journal2022

Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor.

Yasunori Miyamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.